₹418.00
₹418
₹13.93 per unit
BEST VALUE
₹418
(Inclusive of all Taxes)
Get Free delivery (₹99) with



Forglyn Respicap is used for long-term maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tube lining).
Forglyn Respicap is a combination of Formoterol fumarate and Glycopyrronium. Formoterol fumarate prevents airway muscle contraction, making it easier for air to enter and exit the lungs. Glycopyrronium decreases the secretions in the airways.
In some cases, you may experience common side effects such as headache, nausea, dry mouth, chest pain, muscle cramps, dizziness, and frequent urination. Most of these side effects do not require medical attention. However, talk to your doctor if the side effects persist or worsen.
Do not stop taking Forglyn Respicap on your own, as it might cause worsening of symptoms. Consult your doctor if you are pregnant or breastfeeding. Forglyn Respicap is not recommended for children under 18 years old, as safety and effectiveness have not been established. Keep your doctor informed about your health condition and the medicines you are taking to avoid unpleasant side effects.
Forglyn Respicap is used to treat chronic obstructive pulmonary disease (COPD). The detailed uses of Forglyn Respicap are as follows:
Unsafe
You are advised not to consume alcohol while taking Forglyn Respicap as it might cause increased dizziness.
Consult your doctor
Please consult your doctor if you are pregnant; your doctor will prescribe only if the benefits outweigh the risks.
Consult your doctor
Consult your doctor if you are breastfeeding; your doctor will decide whether Forglyn Respicap can be taken by breastfeeding mothers or not.
Caution
Forglyn Respicap may cause dizziness. Drive or operate machinery only if you are alert.
Consult your doctor
Please consult your doctor if you have liver disease or any concerns regarding this.
Consult your doctor
Please consult your doctor if you have kidney disease or any concerns regarding this.
Unsafe
Forglyn Respicap is not recommended for children below 18 years as safety and effectiveness have not been established.
Caution
Forglyn Respicap should be used with caution in patients with heart disease due to increased risk of side effects. Therefore, please consult your doctor before using Forglyn Respicap .
Consult your doctor
Forglyn Respicap should be used in elderly patients only when prescribed by a doctor. If you have any concerns about using Forglyn Respicap in older adults, please consult your doctor.

Have a query?
Login/Sign Up
Login/Sign Up
Forglyn Respicap is indicated for long-term, maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD).
Forglyn Respicap contains Formoterol fumarate and Glycopyrronium. Formoterol fumarate relaxes and widens the openings in the airways, making it easier for air to get in and out of the lungs. Glycopyrronium decreases the secretions in the airways. Together, Forglyn Respicap provides relief from COPD.
Forglyn Respicap is indicated for the maintenance treatment for COPD. It does not treat a sudden attack of wheezing or breathlessness. Use a rescue inhaler to treat sudden breathing problems.
Dry mouth could be a side effect of Forglyn Respicap . Limiting caffeine intake, avoiding smoking and mouthwashes containing alcohol, and drinking water regularly.
Do not stop using Forglyn Respicap on your own, as this might worsen symptoms. To treat your condition effectually, continue using Forglyn Respicap for as long as your doctor has prescribed it. Talk to your doctor if your breathing problems, wheezing, or cough do not improve or worsen.
No, Forglyn Respicap is not indicated for the treatment of asthma, as its safety and effectiveness in patients with asthma have not been established. Consult your doctor if you have asthma.
Consult your doctor if you are diabetic, as it might sometimes raise blood sugar levels. Regular monitoring of blood glucose levels whilst taking Forglyn Respicap is advised.
Disclaimer
We provide you with authentic, trustworthy and relevant information